Kalivendi Shasi V, Kotamraju Srigiridhar, Cunningham Sonya, Shang Tiesong, Hillard Cecilia J, Kalyanaraman B
Biophysics Research Institute and Free Radical Research Center, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA.
Biochem J. 2003 Apr 1;371(Pt 1):151-64. doi: 10.1042/BJ20021525.
1-Methyl-4-phenylpyridinium (MPP(+)) is a neurotoxin used in cellular models of Parkinson's Disease. Although intracellular iron plays a crucial role in MPP(+)-induced apoptosis, the molecular signalling mechanisms linking iron, reactive oxygen species (ROS) and apoptosis are still unknown. We investigated these aspects using cerebellar granule neurons (CGNs) and human SH-SY5Y neuroblastoma cells. MPP(+) enhanced caspase 3 activity after 24 h with significant increases as early as 12 h after treatment of cells. Pre-treatment of CGNs and neuroblastoma cells with the metalloporphyrin antioxidant enzyme mimic, Fe(III)tetrakis(4-benzoic acid)porphyrin (FeTBAP), completely prevented the MPP(+)-induced caspase 3 activity as did overexpression of glutathione peroxidase (GPx1) and pre-treatment with a lipophilic, cell-permeable iron chelator [N, N '-bis-(2-hydroxybenzyl)ethylenediamine-N, N '-diacetic acid, HBED]. MPP(+) treatment increased the number of TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labelling)-positive cells which was completely blocked by pre-treatment with FeTBAP. MPP(+) treatment significantly decreased the aconitase and mitochondrial complex I activities; pre-treatment with FeTBAP, HBED and GPx1 overexpression reversed this effect. MPP(+) treatment increased the intracellular oxidative stress by 2-3-fold, as determined by oxidation of dichlorodihydrofluorescein and dihydroethidium (hydroethidine). These effects were reversed by pre-treatment of cells with FeTBAP and HBED and by GPx1 overexpression. MPP(+)-treatment enhanced the cell-surface transferrin receptor (TfR) expression, suggesting a role for TfR-induced iron uptake in MPP(+) toxicity. Treatment of cells with anti-TfR antibody (IgA class) inhibited MPP(+)-induced caspase activation. Inhibition of nitric oxide synthase activity did not affect caspase 3 activity, apoptotic cell death or ROS generation by MPP(+). Overall, these results suggest that MPP(+)-induced cell death in CGNs and neuroblastoma cells proceeds via apoptosis and involves mitochondrial release of ROS and TfR-dependent iron.
1-甲基-4-苯基吡啶鎓(MPP(+))是一种用于帕金森病细胞模型的神经毒素。尽管细胞内铁在MPP(+)诱导的细胞凋亡中起关键作用,但将铁、活性氧(ROS)与细胞凋亡联系起来的分子信号传导机制仍不清楚。我们使用小脑颗粒神经元(CGNs)和人SH-SY5Y神经母细胞瘤细胞研究了这些方面。MPP(+)在处理细胞12小时后最早显著增加,24小时后增强了半胱天冬酶3的活性。用金属卟啉抗氧化酶模拟物四(4-苯甲酸)铁(III)卟啉(FeTBAP)预处理CGNs和神经母细胞瘤细胞,与过表达谷胱甘肽过氧化物酶(GPx1)以及用亲脂性、细胞可渗透的铁螯合剂[N,N'-双(2-羟基苄基)乙二胺-N,N'-二乙酸,HBED]预处理一样,完全阻止了MPP(+)诱导的半胱天冬酶3活性。MPP(+)处理增加了TUNEL(末端脱氧核苷酸转移酶介导的dUTP缺口末端标记)阳性细胞的数量,而用FeTBAP预处理可完全阻断这一现象。MPP(+)处理显著降低了乌头酸酶和线粒体复合物I的活性;用FeTBAP、HBED预处理和过表达GPx1可逆转这种作用。通过二氯二氢荧光素和二氢乙锭(氢乙锭)的氧化测定,MPP(+)处理使细胞内氧化应激增加了2至3倍。用FeTBAP和HBED预处理细胞以及过表达GPx1可逆转这些作用。MPP(+)处理增强了细胞表面转铁蛋白受体(TfR)的表达,表明TfR诱导的铁摄取在MPP(+)毒性中起作用。用抗TfR抗体(IgA类)处理细胞可抑制MPP(+)诱导的半胱天冬酶激活。抑制一氧化氮合酶活性不影响MPP(+)诱导的半胱天冬酶3活性、凋亡性细胞死亡或ROS生成。总体而言,这些结果表明,MPP(+)在CGNs和神经母细胞瘤细胞中诱导的细胞死亡通过细胞凋亡进行,涉及线粒体释放ROS和TfR依赖性铁。